NCT04106349 - Observational Real-life Study of Cabozantinib in Monotherapy or in Combination With Nivolumab in Advanced Renal Cell Carcinoma (RCC) | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

March 3, 2020

Primary Completion Date

March 31, 2027

Study Completion Date

September 1, 2027

Conditions

Advanced or Metastatic Renal Cell Carcinoma

Trial Locations (25)

1070

WITHDRAWN

Hôpital Erasme, Brussels

1090

RECRUITING

UZ Brussel, Brussels

1160

WITHDRAWN

Chirec Delta, Brussels

1340

RECRUITING

Clinique Saint-Pierre, Ottignies

2300

RECRUITING

AZ Turnhout, Turnhout

2820

RECRUITING

Imeldaziekenhuis, Bonheiden

3500

WITHDRAWN

Virga Jessa Ziekenhuis, Hasselt

3600

RECRUITING

Ziekenhuis Oost-Limburg Genk, Genk

4000

RECRUITING

CHC MontLegia, Liège

RECRUITING

CHR Citadelle Liège, Liège

RECRUITING

CHU Liège / Sart-Tilman, Liège

4800

RECRUITING

CHR Verviers, Verviers

5004

RECRUITING

Clinique Saint-Luc Bouge, Bouge

5530

WITHDRAWN

UCL Namur - site Godinne, Yvoir

6110

RECRUITING

CHU Charleroi - site André Vésale, Montigny-le-Tilleul

6700

WITHDRAWN

Vivalia Hôpital d'Arlon, Arlon

7000

RECRUITING

Hôpital Ambroise-Paré Mons, Mons

7100

RECRUITING

Hôpital de Jolimont, La Louvière

7500

RECRUITING

CHWAPI, Tournai

8000

RECRUITING

AZ Sint-Jan Brugge, Bruges

8310

RECRUITING

AZ Sint-Lucas, Bruges

8800

RECRUITING

AZ Delta, Roeselare

9000

RECRUITING

Universitair Ziekenhuis Gent, Ghent

9300

RECRUITING

Onze-Lieve-vrouw Ziekenhuis Aalst, Aalst

9600

RECRUITING

AZ Glorieux, Ronse